871357-89-0

Basic information

• Product Name: AS703569
• Synonyms: AS703569;R763;Cenisertib;(1S,2S,3R,4R)-3-((5-fluoro-2-((3-Methyl-4-(4-Methylpiperazin-1-yl)phenyl)aMino)pyriMidin-4-yl)aMino)bicyclo[2.2.1]hept-5-ene-2-carboxaMide
• CAS NO: 871357-89-0
• Molecular Formula: C24H30FN7O
• Molecular Weight: 451.5397032
• Mol File: 871357-89-0.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 708.3±70.0 °C(Predicted)
• Appearance: /
• Density: 1.335±0.06 g/cm3(Predicted)
• PKA: 16.24±0.40(Predicted)
• CAS DataBase Reference: AS703569(CAS DataBase Reference)
• NIST Chemistry Reference: AS703569(871357-89-0)
• EPA Substance Registry System: AS703569(871357-89-0)

Safety Data

• Hazardous Substances Data: 871357-89-0(Hazardous Substances Data)

Usage

General Description

AS703569 is a chemical compound that is classified as a diarylpyrimidine and is known to have potent inhibitory activity against the protein kinase known as aurora. AS703569 has been studied for its potential anti-cancer properties, as aurora kinase plays a critical role in cell division and is often overexpressed in cancer cells. AS703569 has shown promising results in preclinical studies, demonstrating its ability to inhibit tumor growth and induce apoptosis in cancer cells. It has also been investigated for its potential to enhance the efficacy of other anti-cancer treatments. Overall, AS703569 appears to be a promising candidate for further development as a potential anti-cancer therapy.